Depression & Mental Health
What Is Treatment-Resistant Depression?
Depression doesn't always improve with the first treatment. Learn what treatment-resistant depression means and why a psychiatric reassessment may help clarify the next steps.
Depression treatment doesn't always follow a straightforward path.
For some people, an antidepressant or psychotherapy provides meaningful improvement. For others, symptoms continue despite trying different treatments and following professional recommendations.
When depression does not improve adequately after appropriate treatment attempts, clinicians may consider whether someone is experiencing treatment-resistant depression, often abbreviated as TRD.
The term can sound discouraging, but it doesn't mean that improvement is impossible or that every treatment option has been exhausted.
Understanding what treatment resistance means is an important part of having an informed conversation about mental-health care.
What does treatment-resistant depression mean?
Treatment-resistant depression generally refers to major depressive disorder that has not responded adequately to appropriate antidepressant treatment.
One commonly used clinical definition involves an insufficient response to at least two different antidepressant medications that were prescribed at appropriate doses and taken for sufficient periods.
However, definitions of treatment resistance can vary. A qualified clinician must consider the medications involved, treatment duration, response, side effects, and other factors before determining whether the term applies.
Someone who has experienced limited improvement after one medication does not automatically meet the usual criteria for treatment-resistant depression.
Likewise, experiencing continued symptoms does not necessarily mean a particular treatment has failed. Sometimes the treatment needs more time, adjustments, or further evaluation.
Why doesn't depression treatment always work?
Depression is a complex condition influenced by multiple biological, psychological, medical, and environmental factors.
Because individuals differ, their responses to treatment can also differ.
Individual treatment response
Antidepressants affect chemical signaling systems involved in mood regulation, but not everyone responds to the same medication in the same way.
One person may experience substantial improvement with a particular treatment, while another may experience only partial improvement or difficult side effects.
The duration and dose of treatment
Many antidepressants require several weeks before their full effects can be assessed.
If a medication was stopped too early, taken inconsistently, or never reached an appropriate dose, a clinician may need to review whether the trial was sufficient.
Other mental-health conditions
Depression can occur alongside anxiety disorders, trauma-related conditions, substance-use disorders, and other mental-health concerns.
Bipolar disorder can also involve depressive episodes, but its treatment considerations differ from those of major depressive disorder.
A comprehensive evaluation can help clarify whether additional conditions influence treatment response.
Physical health and medication factors
Sleep disorders, certain medical conditions, substance use, medication interactions, and other factors can influence mood or complicate treatment.
Reviewing the broader health picture is an important part of psychiatric care.
Changes in personal circumstances
Stress, relationships, major life changes, and other circumstances can influence emotional well-being.
Treatment planning may need to account for these factors alongside medical considerations.
How is treatment-resistant depression evaluated?
There is no single blood test or questionnaire that independently establishes treatment-resistant depression.
Instead, clinicians review the person's psychiatric history and previous treatment experiences.
An evaluation may examine:
- Current depressive symptoms and their effects on daily functioning.
- Previous antidepressants and other psychiatric medications.
- Medication doses and treatment duration.
- Whether medications were taken consistently.
- Side effects or reasons treatment was discontinued.
- Previous psychotherapy and response to counseling.
- Medical conditions and other prescribed medications.
- Sleep patterns, substance use, and coexisting mental-health concerns.
- Previous episodes of depression or possible mood elevation.
The goal is to understand what has happened during earlier treatment and determine which next steps may be appropriate.
What treatment options may be considered?
There isn't one treatment pathway that works for everyone experiencing persistent depression.
The appropriate next step depends on the person's clinical history, diagnosis, treatment response, preferences, and potential risks.
Reviewing the current treatment plan
Sometimes a clinician may recommend adjusting the dose of an existing medication, changing the treatment schedule, or addressing issues that may be interfering with the medication's effectiveness.
Any changes should be made under the guidance of the prescribing professional.
Exploring other antidepressant approaches
A different antidepressant or a combination of medications may be considered.
In some circumstances, clinicians may recommend adding another medication to an existing antidepressant to improve treatment response.
Psychotherapy
Evidence-based psychotherapy can help people address patterns of thinking and behavior, relationships, emotional challenges, and other concerns associated with depression.
For some individuals, psychotherapy is an important component of care alongside medication.
Spravato (esketamine)
Spravato is an FDA-approved prescription nasal spray for treatment-resistant depression in adults.
For this indication, it may be used by itself or alongside an oral antidepressant.
Spravato must be administered in a certified healthcare setting under supervision, with required monitoring after treatment.
Eligibility depends on a clinical evaluation.
Ketamine treatment
Ketamine has been studied for its potential effects on depressive symptoms, particularly in treatment-resistant depression.
However, ketamine itself is not FDA-approved to treat psychiatric disorders. Its use for depression is considered off-label.
Ketamine is not interchangeable with Spravato, and its potential benefits, risks, and suitability require individualized clinical consideration.
Brain stimulation therapies
Other approaches, such as repetitive transcranial magnetic stimulation (rTMS) and electroconvulsive therapy (ECT), may be considered in certain cases of depression that have not responded adequately to previous treatment.
These are distinct treatment approaches and may require referral to an appropriate provider.
Does treatment-resistant depression mean treatment will never work?
No.
Treatment-resistant depression describes an inadequate response to previous treatment attempts. It does not establish that future treatments will be unsuccessful.
The term also does not guarantee that changing medications or pursuing another treatment will produce improvement.
It indicates that a more detailed review of the individual's circumstances and available options may be warranted.
When should someone consider another psychiatric evaluation?
A reassessment may be useful when:
- Depression symptoms persist despite previous treatment.
- A medication has provided only partial improvement.
- Side effects make a treatment difficult to tolerate.
- Symptoms have changed or become more disruptive.
- There are questions about an existing diagnosis.
- Several treatment approaches have been attempted without sufficient benefit.
- Someone wants to understand whether additional options may be appropriate.
An evaluation provides an opportunity to review the complete treatment history rather than making decisions based on a single symptom or medication.
Questions to ask your mental-health provider
Preparing questions before an appointment can help make the conversation more productive.
Consider asking:
- Have my previous medications been given adequate trials?
- Could another condition be influencing my depression symptoms?
- Would psychotherapy or a change in therapy approach be helpful?
- Are there additional medication strategies worth discussing?
- Am I an appropriate candidate for further evaluation for Spravato or another treatment?
- What are the potential risks and limitations of the available options?
- How will we measure whether a treatment plan is helping?
You do not need to arrive at an appointment knowing which treatment you want.
The purpose of the evaluation is to help determine which options are appropriate.
Moving forward with a clearer understanding
Depression can be difficult to navigate when earlier treatment hasn't provided the improvement someone hoped for.
But understanding the reasons behind persistent symptoms can help guide the next conversation.
A thoughtful psychiatric evaluation considers what has already been tried, what remains challenging, and which evidence-based or otherwise clinically appropriate approaches may deserve consideration.
At Neurobody Wellness Center, we emphasize understanding the individual before determining potential treatment pathways.
A different approach begins with understanding your options.
If previous depression treatment hasn't provided sufficient improvement, a psychiatric evaluation may help clarify possible next steps.
Explore Depression Treatment Options
Frequently Asked Questions
How many antidepressants must someone try before depression is considered treatment-resistant?
A commonly used definition involves an inadequate response to at least two appropriate antidepressant trials. Clinical definitions vary, and a provider must evaluate each treatment history individually.
Can treatment-resistant depression improve?
Yes, improvement remains possible. Treatment-resistant depression does not mean that all available care approaches have been exhausted.
Is Spravato available to everyone with depression?
No. Spravato is approved for specific depressive indications in adults, and eligibility requires clinical assessment. It is not appropriate for every patient.
Is ketamine FDA-approved for depression?
No. Ketamine is FDA-approved for anesthetic uses, but psychiatric use for depression is off-label.
Should someone stop taking an antidepressant if it isn't helping?
No medication should be stopped or changed without guidance from the prescribing professional. Abrupt discontinuation may cause withdrawal symptoms or other problems.
Related Reading
- Depression & Treatment-Resistant Depression
- When Antidepressants Haven't Helped Enough
- Ketamine vs. Spravato
- Psychiatric Evaluations
Sources
This article is intended for general educational purposes and does not replace personalized medical advice, diagnosis, or treatment. Treatment decisions should be made in consultation with qualified healthcare professionals. If you are in crisis, call or text 988 or dial 911.
